PR Newswire BiotechOriginal article
Okami Medical Receives Expanded Indication for the LOBO Vascular Occluder
RegulatoryapprovedLOBO Vascular Occlusion SystemPositive
AI Analysis
Summary
Okami Medical announced FDA approval for an expanded indication of its LOBO Vascular Occlusion System, a novel vascular embolization solution.
Outcome Details
FDA granted expanded indication for LOBO Vascular Occlusion System
Importance:7/10
Sentiment:
0.80
FDA approvalexpanded indicationvascular occlusionmedical device
Related Companies
Read the original article
Published by PR Newswire Biotech on October 7, 2026 9:51 PM